Related Experiment Video
Updated: Apr 5, 2026

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
How to manage neonatal tuberculosis
A Di Comite1, S Esposito2, A Villani3
1Department of Neonatology, Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Prompt diagnosis and family screening are crucial for managing neonatal tuberculosis (TB). Early treatment, including pyridoxine for breastfed infants and allowing breastfeeding by smear-negative mothers, improves outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Neonatal tuberculosis (TB) presents diagnostic and management challenges.
- Early identification and treatment are critical for infant survival and preventing transmission.
Purpose of the Study:
- To establish evidence-based recommendations for managing neonatal TB.
- To provide guidance on diagnosis, treatment, and prevention strategies for healthcare professionals.
Main Methods:
- Systematic review of English-language publications from MEDLINE and Cochrane Database of Systematic Reviews (until December 31, 2014).
- Consensus Conference method involving Italian scientific societies.
Main Results:
- Prompt investigation of newborns, mothers, and family contacts is recommended upon suspicion of neonatal TB.
- Empirical treatment should commence if TB suspicion is confirmed.
- Specific guidelines for isoniazid treatment (pyridoxine supplementation) and breastfeeding by mothers with TB are provided.
Conclusions:
- A comprehensive approach involving family screening and prompt treatment is essential for neonatal TB management.
- Recommendations aim to optimize infant outcomes and prevent disease spread within families.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: